Literature DB >> 15115985

Xenoreactivity and engraftment of human mesenchymal stem cells transplanted into infarcted rat myocardium.

K H Grinnemo1, A Månsson, G Dellgren, D Klingberg, E Wardell, V Drvota, C Tammik, J Holgersson, O Ringdén, C Sylvén, K Le Blanc.   

Abstract

OBJECTIVE: It is thought that adult human mesenchymal stem cells do not induce immunoreactivity even to xenografts. We wanted to study whether adult human mesenchymal stem cells survive and engraft in experimentally induced ischemic rat myocardium.
METHODS: Bone marrow-derived adult human mesenchymal stem cells (2.5 x 10(6)) were injected into the myocardium of 4 Sprague-Dawley rats. One week after injection, peripheral blood rat lymphocytes were added to adult human mesenchymal stem cells in a mixed lymphocyte reaction. Furthermore, an infarction was created by left anterior descending artery ligation of 8 Sprague-Dawley rats, 4 of which were immunosuppressed with tacrolimus (0.1 mg/kg/d) and 4 RNU athymic rats. One week after left anterior descending artery ligation, 2.5 to 3.5 x 10(6) adult human mesenchymal stem cells were injected around the infarcted area. The adult human mesenchymal stem cells were identified with fluorescence in situ hybridization technique and myocardial antigens by immunohistochemistry. The immune response was studied by hematoxylin and eosin staining and by antibodies directed toward macrophages.
RESULTS: Significant rat lymphocyte proliferation was observed when adult human mesenchymal stem cells were added to peripheral blood from Sprague-Dawley rats previously exposed to adult human mesenchymal stem cells. No reactivity was seen in lymphocytes from untreated Sprague-Dawley rats and athymic rats. Adult human mesenchymal stem cells could only be identified in the myocardium of athymic rats. Further, in normal Sprague-Dawley rats, there was a significant myocardial infiltration of round cells, mostly macrophages, in the area of injection of adult human mesenchymal stem cells. In RNU rats, this reaction was less intense.
CONCLUSION: Adult human mesenchymal stem cells did not induce xenoreactivity in vitro in previously unexposed immunocompetent Sprague-Dawley rats. However, although mesenchymal stem cells are transplantable across allogeneic barriers, transplant rejection can occur in a xenogenic model. When transplanted into an immunoincompetent host, adult human mesenchymal stem cells showed persistent engraftment.

Entities:  

Mesh:

Year:  2004        PMID: 15115985     DOI: 10.1016/j.jtcvs.2003.07.037

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  69 in total

Review 1.  Cardiac cell therapy: boosting mesenchymal stem cells effects.

Authors:  E Samper; A Diez-Juan; J A Montero; P Sepúlveda
Journal:  Stem Cell Rev Rep       Date:  2013-06       Impact factor: 5.739

2.  Micromanipulation of culture niche permits long-term expansion of dental pulp stem cells--an economic and commercial angle.

Authors:  Vijayendran Govindasamy; Veronica Sainik Ronald; Swapnil Totey; Salina Binti Din; Wan Mahadzir Bin Wan Mustafa; Satish Totey; Zubaidah Zakaria; Ramesh R Bhonde
Journal:  In Vitro Cell Dev Biol Anim       Date:  2010-08-20       Impact factor: 2.416

Review 3.  The stem cell continuum: considerations on the heterogeneity and plasticity of marrow stem cells.

Authors:  Peter J Quesenberry; G Dooner; M Dooner; G Colvin
Journal:  Stem Cell Rev       Date:  2005       Impact factor: 5.739

Review 4.  Immune response to stem cells and strategies to induce tolerance.

Authors:  Puspa Batten; Nadia A Rosenthal; Magdi H Yacoub
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2007-08-29       Impact factor: 6.237

5.  Dielectric study of the adhesion of mesenchymal stem cells from human umbilical cord on a sugarcane biopolymer.

Authors:  A S Fragoso; M B Silva; C P de Melo; J L A Aguiar; C G Rodrigues; P L de Medeiros; J F Branco Junior; C A S Andrade; M D L Oliveira
Journal:  J Mater Sci Mater Med       Date:  2013-09-27       Impact factor: 3.896

6.  HSCT recipients have specific tolerance to MSC but not to the MSC donor.

Authors:  Mikael Sundin; A John Barrett; Olle Ringdén; Mehmet Uzunel; Helena Lönnies; Asa-Lena Dackland; Birger Christensson; Katarina Le Blanc
Journal:  J Immunother       Date:  2009-09       Impact factor: 4.456

7.  Can mesenchymal stem cells induce tolerance to cotransplanted human embryonic stem cells?

Authors:  Etienne Puymirat; Raghed Geha; André Tomescot; Valérie Bellamy; Jérôme Larghero; Ludovic Trinquart; Patrick Bruneval; Michel Desnos; Albert Hagège; Michel Pucéat; Philippe Menasché
Journal:  Mol Ther       Date:  2008-10-07       Impact factor: 11.454

8.  Transplanted xenogenic bone marrow stem cells survive and generate new bone formation in the posterolateral lumbar spine of non-immunosuppressed rabbits.

Authors:  Hyung-Jun Kim; Jong-Beom Park; Jin Kyung Lee; Eun-Young Park; Eun-Ae Park; K Daniel Riew; Seung-Koo Rhee
Journal:  Eur Spine J       Date:  2008-09-25       Impact factor: 3.134

9.  Analysis of chemotactic molecules in bone marrow-derived mesenchymal stem cells and the skin: Ccl27-Ccr10 axis as a basis for targeting to cutaneous tissues.

Authors:  Vitali Alexeev; Adele Donahue; Jouni Uitto; Olga Igoucheva
Journal:  Cytotherapy       Date:  2013-02       Impact factor: 5.414

Review 10.  Cell therapies for traumatic brain injury.

Authors:  Matthew T Harting; James E Baumgartner; Laura L Worth; Linda Ewing-Cobbs; Adrian P Gee; Mary-Clare Day; Charles S Cox
Journal:  Neurosurg Focus       Date:  2008       Impact factor: 4.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.